barinthusbio.com (BRNS) - Market Value

Official company branding of Barinthus Biotherapeutics Corp (BRNS)

The Barinthus Biotherapeutics (BRNS) price chart reflects the performance of a company whose US and UK centers develop immunotherapies to combat viral infections, including HPV and hepatitis B. Market capitalization stands at 0.03, while government grants and R&D alliances reduce development costs, stabilizing the balance sheet. Expected results from mid-stage vaccine trials will serve as growth catalysts, and current operating losses are already priced in.

BRNS Barinthus Biotherapeutics plc: Market Capitalization in the range 02/21/2024 - 09/19/2026

Comprehensive metric breakdowns and analytics for Barinthus Biotherapeutics (BRNS)

- market price and analyst price targets:
- market capitalization indicators:
Fundamental company analysis:BRNS (Barinthus Bio)
Product sample of Barinthus Biotherapeutics Corp

Market capitalization reflects the total value of all the issuer's shares based on current exchange quotes. Investors use this aggregated metric to assess the scale of the business and determine the fair value of the asset. By analyzing the history of a company's market capitalization, one can identify periods of overvaluation or undervaluation of the securities. For Barinthus Biotherapeutics (BRNS), the chart's dynamics confirm market confidence in the development of T-cell immunotherapies. The high capitalization valuation here correlates with the brand's scientific authority in oncology treatment.

Key competitors

Market Value Argenx ARGX|BNTX: Market Capitalization|ABVX: Market Valuation|ADMA Biologics (ADMA) - Market Valuation|PTGX (Protagonist Therapeutics Inc) - Market Valuation|IMVT: Market Value|Market Value Kiniksa|Grifols Group - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Therapeutics) - Market Value|Market Capitalization AUPH (auriniapharma.com)|Market Capitalization BioCryst Pharmaceuticals, Inc. BCRX|VERA - Market Value|Market Value DNTH (Dianthus Corp)|pharvaris.com (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc|TRML (tourmalinebio.com) - Market Capitalization|Market Capitalization Intrexon|Market Valuation PHAR (Pharming)|NKTR (Nektar) - Market Value|Market Value upstreambio.com UPB|Market Capitalization zenasbio.com (ZBIO)|IMNM - Market Value|Gossamer Bio Inc (GOSS) - Market Valuation|KalVista Corp (KALV) - Market Value|Market Valuation Septerna Inc|Market Valuation PVLA|Market Capitalization savarapharma.com|Market Value Rigel Pharmaceuticals Inc (RIGL)|AnaptysBio - Market Capitalization|Market Capitalization ATXS (astriatx.com)|enGene Bio (ENGN) - Market Value|RAPT - Market Value|JBIO - Market Capitalization|ACRS: Market Capitalization|Market Value Kyverna (KYTX)|Market Valuation TLSA|Market Value CABA|Market Valuation VTYX (Ventyx Bio)|THTX (Theratechnologies Inc.) - Market Value|Market Value Avalo Therapeutics Inc AVTX|Eledon Pharmaceuticals Inc. (ELDN) - Market Value|AGEN - Market Value|Market Value CLYM (Climb Bio, Inc.)|ZURA: Market Capitalization|aTyr Pharma, Inc. - Market Value|ADAG (Adagene Corp) - Market Capitalization|ikenaoncology.com (IMA) - Market Capitalization|Market Valuation STTK (Shattuck Labs Inc)|Market Capitalization Equillium Inc|Market Capitalization CNTB (connectbiopharm.com)|IMUX: Market Capitalization|Atara Bio - Market Capitalization|IFRX: Market Value|XFOR: Market Capitalization|Market Valuation Adicet Bio Inc.|Market Value Celularity|Market Capitalization INMB (INmune Bio, Inc.)|Market Capitalization KZR|SABS - Market Value|Akari Therapeutics Plc - Market Valuation|enlivex.com (ENLV) - Market Value|QTTB - Market Value|Market Capitalization GeoVax Labs, Inc. GOVX|EDSA: Market Capitalization|iBio Inc - Market Value|CARM (Carisma Therapeutics Inc.) - Market Capitalization|XTL Biopharmaceuticals, Ltd. (XTLB) - Market Capitalization|Market Capitalization BOLT|HCWB (HCW Biologics) - Market Value|Market Capitalization APVO (Aptevo Therapeutics, Inc.)|Market Value AIM|ADTX: Market Valuation|Market Value GRI (GRI Bio Corp)|XRTX: Market Capitalization|Market Capitalization HIND|Market Value Revelation Biosciences, Inc.|Market Capitalization INDP (Indaptus Therapeutics, Inc.)|Market Capitalization SCNI|CALI (CalciMedica Inc) - Market Value|Market Capitalization AFMD (Affimed NV)|ALLK - Market Valuation|HOOKIPA Pharma Inc. - Market Capitalization|Market Value IGMS (igmbio.com)|iTeos Pharma (ITOS) - Market Value|Ocean Bio - Market Value|TCBP (TC BioPharm (Holdings) Plc) - Market Capitalization|Market Capitalization Third Harmonic Bio, Inc.